Cancer
Credibility 80
HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer.
August 4, 2026 · Molecular cancer research : MCR
Key takeaway
This study found that prostate cancers with a specific gene change (PTEN loss) have more immune cells, which is good because it means the body might fight the cancer better. This matters for Black men because it could lead to new, targeted treatments for prostate cancer in our community.
Why this matters for our communities
Research in cancer helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Cancer
February 1, 2027Dual-modal immunoassay for prostate cancer-derived exosomes enabled by a black phosphorus/silver SERS substrate and Yb/Er co-doped NaGdF4 UCL nanoprobes.Read December 18, 2026Factors Associated with Screening Mammography Utilization Among Women Veterans in VA Primary Care.Read November 16, 2026Characterizing prior symptomatic emergency department visits among patients undergoing unplanned colon cancer surgery.Read